Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17428ExperimentalSmall molecule
YK-4-279: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Transcription factor PU.1, Transcriptional regulator ERG, and ETS translocation variant 1
- Also known as
- (S)-YK-4-279 · 4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one · Efdispo
- Code names
- YK-4-279
Resolves to
Compound
What you can answer from here — as of July 08, 2026
4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with YK-4-279, and which of those have an active Phase 3 trial?